The impact of diabetes mellitus on healthcare costs
暂无分享,去创建一个
[1] C. Weber,et al. Impact of self-measurement of blood glucose on complications of type 2 diabetes: economic analysis from a Czech perspective , 2010, Current medical research and opinion.
[2] R. Gnavi,et al. The impact of second‐level specialized care on hospitalization in persons with diabetes: a multilevel population‐based study , 2006, Diabetic medicine : a journal of the British Diabetic Association.
[3] M. Brito-Sanfiel,et al. Economic impact of hypoglycemia on healthcare in Spain , 2010, Expert review of pharmacoeconomics & outcomes research.
[4] S. Wild,et al. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. , 2004, Diabetes care.
[5] V. Foos,et al. Self-monitoring of blood glucose (SMBG) in patients with type 2 diabetes on oral anti-diabetes drugs: cost-effectiveness in France, Germany, Italy, and Spain , 2010, Current medical research and opinion.
[6] Dario Gregori,et al. Factors affecting hospitalization costs in Type 2 diabetic patients. , 2009, Journal of diabetes and its complications.
[7] Sandra L. Tunis,et al. Self-monitoring of blood glucose (SMBG) for type 2 diabetes patients treated with oral anti-diabetes drugs and with a recent history of monitoring: cost-effectiveness in the US , 2010, Current medical research and opinion.
[8] D. Voinovich,et al. Major complications have an impact on total annual medical cost of diabetes: results of a database analysis. , 2006, Journal of diabetes and its complications.
[9] Cost impact of self-measurement of blood glucose on complications of type 2 diabetes: the Spanish perspective. , 2009, Diabetes technology & therapeutics.
[10] J. O'brien,et al. Direct Medical Costs of Complications Resulting From Type 2 Diabetes in Hie U.S. , 1998, Diabetes Care.
[11] A. Nicolucci,et al. The Italian Diabetes and Exercise Study (IDES): design and methods for a prospective Italian multicentre trial of intensive lifestyle intervention in people with type 2 diabetes and the metabolic syndrome. , 2008, Nutrition, metabolism, and cardiovascular diseases : NMCD.
[12] K. Flegal,et al. Prevalence of Diabetes, Impaired Fasting Glucose, and Impaired Glucose Tolerance in U.S. Adults: The Third National Health and Nutrition Examination Survey, 1988–1994 , 1998, Diabetes Care.
[13] M. Massi-Benedetti. The Cost of Diabetes Type II in Europe The CODE-2 Study , 2002, Diabetologia.
[14] S. Laditka,et al. Health care use of individuals with diabetes in an employer-based insurance population. , 2001, Archives of internal medicine.
[15] J. Shaw,et al. Global and societal implications of the diabetes epidemic , 2001, Nature.
[16] F. Chiarelli,et al. Technology and the issue of cost/benefit in diabetes , 2009, Diabetes/metabolism research and reviews.
[17] D. Jeffries,et al. Modelling the costs of care of hypertension in patients with metabolic syndrome and its consequences, in Germany, Spain and Italy , 2011, The European Journal of Health Economics.
[18] Jonathan B. Brown,et al. The progressive cost of complications in type 2 diabetes mellitus. , 1999, Archives of internal medicine.
[19] B. Schneider,et al. Cost impact of blood glucose self-monitoring on complications of type 2 diabetes: a Swiss perspective (ROSSO study No.11). , 2007, Swiss medical weekly.
[20] A. Nicolucci,et al. Effect of an intensive exercise intervention strategy on modifiable cardiovascular risk factors in subjects with type 2 diabetes mellitus: a randomized controlled trial: the Italian Diabetes and Exercise Study (IDES). , 2010, Archives of internal medicine.
[21] Simanis Jg. Health care expenditures: international comparisons, 1970-80. , 1987 .
[22] G. Goodall,et al. Evaluating the cost-effectiveness of self-monitoring of blood glucose in type 2 diabetes patients on oral anti-diabetic agents. , 2010, Swiss medical weekly.
[23] U. Gerdtham,et al. Economic Evaluation of Lifestyle Interventions for Preventing Diabetes and Cardiovascular Diseases , 2010, International journal of environmental research and public health.
[24] G. Bruno,et al. The impact of diabetes on prescription drug costs: the population-based Turin study , 2008, Diabetologia.
[25] H. King,et al. Global Burden of Diabetes, 1995–2025: Prevalence, numerical estimates, and projections , 1998, Diabetes Care.
[26] M. Engelgau,et al. Cost-of-Illness Studies in Diabetes Mellitus , 2012, PharmacoEconomics.
[27] G. Onder,et al. Pharmacoeconomics and Aging , 2009, Drugs & aging.
[28] Ping Zhang,et al. Cost-Effectiveness of Interventions to Prevent and Control Diabetes Mellitus: A Systematic Review , 2010, Diabetes Care.
[29] G. Marchesini,et al. The direct economic cost of pharmacologically-treated diabetes in Italy-2006. The ARNO observatory. , 2011, Nutrition, metabolism, and cardiovascular diseases : NMCD.
[30] D N Mendelson,et al. Health care expenditures for people with diabetes mellitus, 1992. , 1994, The Journal of clinical endocrinology and metabolism.
[31] M. Laakso,et al. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. , 1998, The New England journal of medicine.
[32] M. Magoni,et al. The evolving burden of HIV infection compared with other chronic diseases in northern Italy * , 2011, HIV medicine.
[33] S. Bo,et al. Evaluating hospital costs in type 2 diabetes care: does the choice of the model matter?* , 2006, Current Medical Research and Opinion.
[34] D. Jeffries,et al. Epidemiological and economic burden of metabolic syndrome and its consequences in patients with hypertension in Germany, Spain and Italy; a prevalence-based model , 2010, BMC public health.
[35] A. Amos,et al. The Rising Global Burden of Diabetes and its Complications: Estimates and Projections to the Year 2010 , 1997, Diabetic medicine : a journal of the British Diabetic Association.